The Universal Forest Products, Inc. Long-Term Incentive Plan (the "Plan") was approved by the Company's shareholders in ​.

The Universal Forest Products, Inc. Executive Stock Grant Program (the "Program") was established by the Company on ​, under the Company's Long Term Stock Incentive Plan, and was amended and restated as of ​, and was further amended effective on ​, ​, and ​, respectively.

UNIVERSAL FOREST PRODUCTS, INC.

FOURTH AMENDMENT TO THE UNIVERSAL FOREST PRODUCTS, INC. EXECUTIVE STOCK GRANT PROGRAM as adopted by the Board of Directors of Universal Forest Products, Inc. (the "Company") with reference to the following:

AMENDMENT TO THE UNIVERSAL FOREST PRODUCTS, INC. LONG-TERM INCENTIVE PLAN as adopted by the Board of Directors of Universal Forest Products, Inc. (the "Company") ​ (the "Effective Date"), with reference to the following:

​, f/k/a Universal Forest Products, Inc., as Company and a Borrower

PURPOSE. The purpose of the Universal Forest Products, Inc. 2002 Employee Stock Purchase Plan (the "Plan") is to provide employees of Universal Forest Products, Inc. (the "Company") and its "Participating Subsidiaries" (as herein defined) with a further inducement to continue their employment with the Company or the Participating Subsidiaries and to encourage such employees to increase their efforts to promote the best interests of the Company. The Plan allows Eligible Employees to purchase shares of common stock of the Company (the "Stock"), at a price less than the market price pursuant to Section 423 of the Internal Revenue Code of 1986, as amended (the "Code"). The Plan succeeds the Company's existing Employee Stock Purchase Plan that was adopted by its shareholders in ​ (the "1994 Plan").

151050 Paper & Forest Products

Products. Subject to the terms and conditions of this Agreement, on a Product-by-Product basis, effective as of the date on which the Collaboration Antigen of such Product becomes a “Collaboration Antigen” under this Agreement, SGI hereby grants to Unum a co-exclusive (with SGI), sublicensable (solely as permitted in accordance with [Section 10.4]), license, under the SGI Background Technology and SGI Program IP, to Commercialize the Product in the Shared Territory (and Manufacture same but only for such purpose and only as provided in this Agreement); provided that such licenses will automatically terminate, and be of no further force or effect, with respect to any Development Candidate and associated Product for which Unum has exercised its Opt-Out Right.

Biosimilar Products. If one or more Biosimilar Products with respect to a Licensed Product is sold commercially by one Biosimilar (or Interchangeable) Applicant in a particular country in the Territory during a particular calendar quarter (“Biosimilar Product Presence”), and during such calendar quarter the Net Sales of such Licensed Product has decreased by ​ percent (​) or more when compared to peak Net Sales of such Licensed Product in such country in ​, and such decrease is attributable to such Biosimilar Product Presence, then the royalty rate (used with Net Sales to determine royalty payments) for such Licensed Product in such country during such calendar quarter and for the remainder of the Royalty Term will be reduced by ​ percent (​) for purposes of determining Arcus’s obligation to make royalty payments under this Agreement. Notwithstanding any other provision of this Agreement, Arcus will at all times pay a minimum royalty of ​ percent (​) of Net Sales under [Section 5.4].